Who will benefit from treatment against EGFR?

Lancet Oncology

Volumn 6, Issue 5, 2005, Pages 257-258

  Arribas, Joaquín ^a   Baselga, José ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; GEFITINIB; PANITUMUMAB;

CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; COLORECTAL CANCER; CORRELATION ANALYSIS; DRUG TARGETING; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC HETEROGENEITY; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MALIGNANT TRANSFORMATION; METASTASIS; NONHUMAN; NOTE; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; SOMATIC MUTATION; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME; WILD TYPE;

EID: 17844393343     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(05)70142-X     Document Type: Letter

References (8)

1. Pao W Miller VA Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions J Clin Oncol 23 2005 2556-2568
2. Yarden Y Sliwkowski MX Untangling the ErbB signalling network Nat Rev Mol Cell Biol 2 2001 127-137
3. Meyerhardt JA Mayer RJ Systemic therapy for colorectal cancer N Engl J Med 352 2005 476-487
4. LB Saltz NJ Meropol PJ Loehrer Sr et al. Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor J Clin Oncol 22 2004 1201-1208
5. KY Chung J Shia NE Kemeny et al. Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry J Clin Oncol 23 2005 1803-1810
6. M Moroni S Veronese S Benvenuti et al. Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: A cohort study Lancet Oncol 6 2005 279-286
7. FR Hirsch M Varella-Garcia PA Bunn Jr et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: Correlation between gene copy number and protein expression and impact on prognosis J Clin Oncol 21 2003 3798-3807
8. W Pao TY Wang GJ Riely et al. KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib PLoS Med 2 2005 e17